Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+1.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Assets Growth (3y) (2018 - 2025)

Analysis

Immuron (IMRN) Assets Growth (3y) (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn
10 Immuron 7.25 Mn -1.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 305.63%
Jun 30, 2025 -28.57%
Dec 31, 2024 249.91%
Jun 30, 2024 -21.06%
Jun 30, 2023 53.48%
Jun 30, 2022 43.72%
Jun 30, 2021 43.86%
Jun 30, 2020 -13.24%
Jun 30, 2019 -3.10%
Jun 30, 2018 14.36%
API Access

Immuron Assets Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets-growth-3y&ticker=IMRN&period=max&api_key=YOUR_API_KEY